FDA Approves PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE — Dr.Reddys Laboratories Inc
Dr. Reddys Laboratories Inc. has secured FDA approval for its ANDA82176 generic version of Qsymia (phentermine and topiramate extended-release), entering a significant weight-management market following manufacturer side effects. This approval creates competitive pressure on brand-name pricing in the $1 billion plus GLP-1 weight trend.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day